About Elysia Group

Our Background & Mission

Elysia was formed in 2014 to bridge the gaps between commercial and health economic teams by generating value spanning the interest of multiple stakeholders

To solve issues, we take a rigorous academic approach while creating deliverables that are simple, easy to interpret, and focus on advancing the commercial agenda

We have an agile, full-time team including PhD modelers and analysts to support day-to-day operations and projects. We also draw from a pool of leading experts in economics and clinical practice


Bruce Wang, PhD

Bruce is a Co-Founder and Chief Executive Officer of Elysia Group. He brings deep expertise in modeling with a particular focus on economic models. Currently, he is also Affiliate Faculty at University of Washington.

Previously, Bruce led the HEOR group at Alliance Life Sciences where he was Vice President. He was also Visiting Senior Fellow at Taipei Medical University in Taiwan, Senior Fellow in the Pharmaceutical Outcomes Research & Policy Program at the University of Washington, and Economic Strategist at Goldman Sachs in New York.

Bruce holds a Ph.D. in Economics from the University of Washington and a B.A. from Columbia University in New York.

Wes Furnback

Wes is a Co-Founder and President of Elysia Group. He specializes in working with clients to understand their needs and develop study that bring the most value to the organization. He has experience in several disease areas including oncology, rheumatology, endocrinology, and infectious diseases.

Wes previously was a senior consultant at Alliance Life Sciences Consulting Group He holds a bachelor’s degree in Economics from the University of Maryland, College Park.